COMMD1 and non-small cell lung carcinoma: Our immunoblotting experiments corroborated the qRT-PCR as well as clinical in vitro data, where COMMD1 protein levels were statistically upregulated in the majority of NSCLC assessed, relative to the HBEC3-KT cell line.